Synopsis
Offer and obtain a high-quality newborn blood-spot sample at the correct time, manage prematurity, transfusion, relocation and repeat needs, communicate presumptive-positive results accurately and ensure screening never delays assessment of a symptomatic baby.
- Newborn blood-spot screening is an offered population screen, not a diagnostic test. Explain purpose, possible results, limitations, storage and follow-up and document informed parental choice or decline.
- In England the routine sample is normally taken on day 5, counting birth as day 0; collect promptly when late rather than abandoning screening because the ideal window passed.
- The England panel now includes sickle cell disease, cystic fibrosis, congenital hypothyroidism and seven inherited metabolic diseases including hereditary tyrosinaemia type 1; panels and operational details can differ across UK nations.
- Spinal muscular atrophy is not part of that routine England panel: an in-service evaluation is scheduled from October 2026, while Scotland's evaluation began in March 2026, so check current local and laboratory coverage as rollout evolves.
- Use the current national card and identifiers, confirm baby and mother details and record feeding, gestation, transfusion and other information that changes interpretation.
- Warm and position the foot, use the safe heel area, let a large hanging drop soak through each required circle from one side and avoid squeezing, layering, contamination or touching the filter paper.
- Inspect both sides for complete saturation, dry horizontally away from heat and contaminants and dispatch through the screened laboratory pathway without avoidable delay.
- Premature babies, transfused babies, babies receiving parenteral nutrition and babies moving between services may need extra or repeat samples under national laboratory rules; document ownership explicitly.
- A presumptive-positive result means the screening marker crossed a referral threshold, not that the diagnosis is certain. Use the condition-specific urgent clinical referral and confirmatory pathway.
- A negative result reduces risk only for the screened targets. If a baby is jaundiced, vomiting, losing weight, hypoglycaemic, encephalopathic or otherwise unwell, investigate and treat the clinical syndrome immediately.
- Track every card from offer to laboratory receipt and final result, act on rejected or incomplete samples promptly and use failsafe systems for families who move or cannot be contacted.
Key red flags
A clinically unwell baby must be investigated directly even when the blood-spot sample was taken or reported normal.
No laboratory receipt or result in the record is a missing safety step, not evidence of a negative screen.
Wrong identifiers or a card belonging to another baby can cause catastrophic delayed or inappropriate referral.
An inadequate sample request needs rapid recollection because several screened conditions cause harm before symptoms become obvious.
Transfusion before sampling can mask haemoglobin patterns and alter other results, requiring laboratory-directed repeat planning.
A presumptive-positive result requires the specified clinical pathway and must not be softened into routine follow-up.
Families moving between nations or services need active reconciliation because panel and repeat rules may differ.
Clinical deterioration before or after a normal card requires direct emergency investigation rather than waiting for or repeating routine screening.
Investigation priorities
Obtain dried capillary blood at the programme time for validated population screening assays.
Management branches
A newborn reaches the national programme sampling window and is clinically stable.
- Provide accessible information on conditions, limitations, storage, results and choices and document consent or informed decline.
- Verify identifiers and special circumstances, collect complete single-application spots from the safe heel area and check both sides.
- Air-dry and dispatch promptly, document collection and transport and tell parents how and when the result will be communicated.